The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany

Enhanced quadrivalent influenza vaccines that include an adjuvant (aQIV) or a high dose of antigen (QIV-HD), which stimulate a stronger immune response in older adults than the standard vaccine (QIVe), are now approved. The objective of this research is to compare available vaccines and determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohli, Michele A., Maschio, Michael, Cartier, Shannon, Mould-Quevedo, Joaquin, Fricke, Frank-Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503029/
https://www.ncbi.nlm.nih.gov/pubmed/36146464
http://dx.doi.org/10.3390/vaccines10091386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503029/
https://www.ncbi.nlm.nih.gov/pubmed/36146464
http://dx.doi.org/10.3390/vaccines10091386

Ejemplares similares